Stock Performance Review on Medical Supplies Industry -- TransEnterix, Dextera Surgical, Ekso Bionics, and Mazor Robotics

Thursday, July 6, 2017 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, July 6, 2017 /PRNewswire/ --

If you want a Stock Review on TRXC, DXTR, EKSO or MZOR then come over to

and sign up for your free customized report today. On Wednesday, the NASDAQ Composite ended the day at 6,150.86, up 0.67%; the Dow Jones Industrial Average edged 0.01% lower, to finish at 21,478.17; and the S&P 500 closed at 2,432.54, marginally
gaining 0.15%. US markets saw a mixed session as 4 sectors closed in green, 4 sectors finished in red, and 1 sector ended flat for the day. has initiated research reports on the following Medical Instruments & Supplies stocks: TransEnterix Inc. (NYSE MKT: TRXC), Dextera Surgical Inc. (NASDAQ: DXTR), Ekso Bionics Holdings Inc. (NASDAQ: EKSO), and Mazor Robotics Ltd (NASDAQ: MZOR). Daily Stock Tracker published comprehensive and free research reports on these stocks today at:


Morrisville, North Carolina headquartered TransEnterix Inc.'s stock finished Wednesday's session 0.17% lower at $0.69 with a total trading volume of 581,001 shares. The Company's shares have surged 34.69% in the past month. The stock is trading 11.53% above its 50-day moving average. Additionally, shares of TransEnterix, which focuses on the development and commercialization of surgical robotic systems, have a Relative Strength Index (RSI) of 60.19. TRXC complete research report is just a click away and free at:

Dextera Surgical 

On Wednesday, shares in Redwood City, California-based Dextera Surgical Inc. recorded a trading volume of 5.30 million shares. The stock ended the session 4.21% lower at $0.32. The Company's shares have advanced 63.31% in the last one month. The stock is trading 14.39% below its 50-day moving average. Moreover, shares of Dextera Surgical, which designs and manufactures proprietary stapling devices for minimally invasive surgical procedures in the US, Japan, Germany, and internationally, have an RSI of 49.71. The complimentary report on DXTR can be downloaded at:

Ekso Bionics 

Richmond, California headquartered Ekso Bionics Holdings Inc.'s shares closed the day 0.87% lower at $2.27. The stock recorded a trading volume of 580,150 shares. The Company's shares have surged 87.60% in the last month. The stock is trading 18.96% above its 50-day moving average. Additionally, shares of Ekso Bionics, which designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, Middle-East, and Africa, have an RSI of 56.69. Sign up for your complimentary research report on EKSO at:

Mazor Robotics 

Shares in Caesarea, Israel-based Mazor Robotics Ltd finished 4.93% higher at $35.79. The stock recorded a trading volume of 262,110 shares. The Company's shares have advanced 20.95% in the previous three months and 63.28% on an YTD basis. The stock is trading above its 200-day moving average by 31.75%. Furthermore, shares of Mazor Robotics, which together with its subsidiary, Mazor Robotics Inc., is engaged in the development, production, marketing, and servicing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the US, Western Europe, Eastern Europe, and Asia, have an RSI of 53.68. Get free access to your research report on MZOR at:


Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store